-
Je něco špatně v tomto záznamu ?
Role of alpha1- and alpha2-adrenoceptors in the regulation of locomotion and spatial behavior in the active place avoidance task: a dose-response study
A Stuchlik, K Vales
Jazyk angličtina Země Irsko
Grantová podpora
NR9178
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- alfa blokátory farmakologie MeSH
- alfa-1-adrenergní receptory - antagonisté MeSH
- alfa-1-adrenergní receptory metabolismus MeSH
- alfa-2-adrenergní receptory - antagonisté MeSH
- alfa-2-adrenergní receptory metabolismus MeSH
- alfa-adrenergní receptory metabolismus MeSH
- financování organizované MeSH
- idazoxan farmakologie MeSH
- krysa rodu rattus MeSH
- mozek metabolismus účinky léků MeSH
- pohybová aktivita fyziologie účinky léků MeSH
- poruchy paměti chemicky indukované patofyziologie MeSH
- potkani Long-Evans MeSH
- prazosin farmakologie MeSH
- učení vyhýbat se fyziologie účinky léků MeSH
- vnímání prostoru fyziologie účinky léků MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
Studies on the neurotransmitter substrate of locomotion and place navigation occupy a central position in behavioral neuroscience. Active allothetic place avoidance (AAPA) is a task, in which animals are trained to avoid a room frame defined stable sector on a continuously rotating arena. The aim of the present study was to test the effect of the blockage of alpha1- and alpha2-adrenoceptors, using specific antagonists prazosin and idazoxan, on the locomotor activity and spatial behavior in the AAPA task. Both prazosin and idazoxan at the highest doses (4 and 6 mg/kg, respectively) were found to decrease the locomotor activity in the AAPA and they also impaired navigational performance. The results suggest that antagonizing alpha-adrenoceptors with systemically administered drugs affects locomotor activity together with avoidance behavior and does not cause a purely cognitive deficit in the AAPA task.
Citace poskytuje Crossref.org
- 000
- 03113naa 2200505 a 4500
- 001
- bmc11003203
- 003
- CZ-PrNML
- 005
- 20140410112938.0
- 008
- 110225s2008 ie e eng||
- 009
- AR
- 024 __
- $a 10.1016/j.neulet.2008.01.013 $2 doi
- 035 __
- $a (PubMed)18255226
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Stuchlík, Aleš, $d 1974- $7 xx0014340
- 245 10
- $a Role of alpha1- and alpha2-adrenoceptors in the regulation of locomotion and spatial behavior in the active place avoidance task: a dose-response study / $c A Stuchlik, K Vales
- 314 __
- $a Department of Neurophysiology of Memory and Computational Neuroscience, Institute of Physiology, Academy of Sciences, Videnska 1083, 142 20 Prague 4, Czech Republic. stuchlik@biomed.cas.cz
- 520 9_
- $a Studies on the neurotransmitter substrate of locomotion and place navigation occupy a central position in behavioral neuroscience. Active allothetic place avoidance (AAPA) is a task, in which animals are trained to avoid a room frame defined stable sector on a continuously rotating arena. The aim of the present study was to test the effect of the blockage of alpha1- and alpha2-adrenoceptors, using specific antagonists prazosin and idazoxan, on the locomotor activity and spatial behavior in the AAPA task. Both prazosin and idazoxan at the highest doses (4 and 6 mg/kg, respectively) were found to decrease the locomotor activity in the AAPA and they also impaired navigational performance. The results suggest that antagonizing alpha-adrenoceptors with systemically administered drugs affects locomotor activity together with avoidance behavior and does not cause a purely cognitive deficit in the AAPA task.
- 650 _2
- $a alfa-1-adrenergní receptory - antagonisté $7 D058668
- 650 _2
- $a alfa-2-adrenergní receptory - antagonisté $7 D058669
- 650 _2
- $a alfa blokátory $x farmakologie $7 D000317
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a učení vyhýbat se $x fyziologie $x účinky léků $7 D001362
- 650 _2
- $a mozek $x metabolismus $x účinky léků $7 D001921
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a idazoxan $x farmakologie $7 D019329
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a poruchy paměti $x chemicky indukované $x patofyziologie $7 D008569
- 650 _2
- $a pohybová aktivita $x fyziologie $x účinky léků $7 D009043
- 650 _2
- $a prazosin $x farmakologie $7 D011224
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Long-Evans $7 D020318
- 650 _2
- $a alfa-adrenergní receptory $x metabolismus $7 D011942
- 650 _2
- $a alfa-1-adrenergní receptory $x metabolismus $7 D018340
- 650 _2
- $a alfa-2-adrenergní receptory $x metabolismus $7 D018341
- 650 _2
- $a vnímání prostoru $x fyziologie $x účinky léků $7 D013028
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Valeš, Karel $7 xx0070865
- 773 0_
- $t Neuroscience Letters $w MED00003507 $g Roč. 433, č. 3 (2008), s. 235-240 $x 0304-3940
- 910 __
- $a ABA008 $b x $y 7 $z 0
- 990 __
- $a 20110413120327 $b ABA008
- 991 __
- $a 20140410113027 $b ABA008
- 999 __
- $a ok $b bmc $g 830558 $s 695196
- BAS __
- $a 3
- BMC __
- $a 2008 $b 433 $c 3 $d 235-240 $i 0304-3940 $m Neuroscience letters $n Neurosci. lett. $x MED00003507
- GRA __
- $a NR9178 $p MZ0
- LZP __
- $a 2011-2B/ipme